Monika is a life sciences specialist with a track record of achieving successful outcomes for clients in challenging cases. She has particular expertise in contentious proceedings at the European Patent Office, often involving multiple parties, and in advising on strategically significant patent portfolios. She regularly provides freedom to operate and validity opinions and has also coordinated and advised on major IP due diligence projects.
With a background that is legal as well as scientific, and by combining a strategic approach with attention to detail, Monika has built a reputation for her advocacy in EPO examination and opposition proceedings. She has represented some of the world's most innovative organisations in the healthcare and pharmaceutical sector in technical areas including cancer immunotherapy, microbiome therapeutics, gene therapy, therapeutic nucleotides and peptides, personalised medicine using AI and machine learning, antibody discovery and diagnostics. She also advises clients harnessing the power of biotechnology and microbiology in the agriculture, food and cosmetics sector.
Monika joined EIP from a position as partner at another UK IP firm. Her professional experience spans over fifteen years and includes private practice firms in the UK and India as well as in-house experience supporting the biologicals and biopharma teams at a global healthcare company.
CIPA Council Member 2021-2023